Lumos Diagnostics

Is there anything you would like to make delegates aware of ahead of the Infection Prevention and Control Conference

Diagnosing and cohorting COVID-19 patients in the emergency department (ED) remains a challenge because of the long turnaround times of lab SARS CoV-2 PCR testing and the need to repeat tests due to false negative results. Consequently, COVID-19 negative patients are exposed to positive patients leading to spread of infection.

FebriDx® is a 10-minute point-of-care test to differentiate viral from bacterial acute respiratory infections and has been shown to be highly accurate in detecting COVID-19 infections and identifying infections missed by RT-PCR. FebriDx can enable effective triaging, so viral negative patients can be rapidly cohorted in non-COVID-19 areas allowing viral positive patients to be immediately isolated whilst awaiting confirmatory testing. In a real World setting at a UK hospital, a FebriDx led algorithm was demonstrated to reduce the need for 2,859 patients to be admitted to isolation rooms over a 3-month period with a 99.7% NPV.

What do you feel are the key points delegates need to digest when considering a partnership with your organisation?
FebriDx can benefit EDs and other healthcare settings overcoming the limitations of lab-based PCR tests. FebriDx is highly accurate to rapidly triage and cohort COVID-19 positive patients from negative patients, reducing risk of transmission and improving clinic workflow.

Do you want to add any other key points?
Rapid triaging with FebriDx can prevent the spread of infection and is easy to implement. FebriDx has been evaluated in pre and post Pandemic studies and has high utility to differentiate viral from bacterial acute respiratory infections. FebriDx is the ideal Rapid Triage test for Healthcare professionals.

Contact Information: